India’s pharmaceutical export sector is regaining momentum, with industry leaders expressing confidence in achieving double-digit growth in the near term. Strengthening global demand, a shift toward higher-value formulations, and improved supply-chain stability have lifted overseas shipments after a period of moderation. Exporters are increasingly focusing on complex generics, specialty drugs, and regulated markets to drive sustainable value growth rather than relying solely on volumes.